High materiality8/10
Raymond James Reiterates Strong Buy Rating on Tyra Biosciences (TYRA)
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
TYRA target raised to $50 from a current price of $20.93 by Raymond James; substantial upside implied.
- Target $50; price $20.93; substantial upside.
Key facts
- 01
Target: $50
- 02
Posted price: $20.93
- 03
Analyst firm: Raymond James
- 04
Analyst: Chris Raymond
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.